Biomapas Insights: From Hope to Global Impact – How Elpida Accelerated Gene Therapy for Rare Diseases
In this Biomapas Insights episode, Martijn van de Leur, Chief Commercial Officer, speaks with Terry Pirovolakis, CEO of Elpida Therapeutics, the organisation that grew out of the CureSPG50 advocacy movement. Together, they explore how a parent-led mission to help...
Biomapas Insights: Selecting the Right CRO at the right time – What Biotechs Need to Know
In this episode, Indrė Dryžienė, Head of Clinical Operations Project Management at Biomapas, is joined by Samson Fung, Managing Director of Fung Consulting Healthcare & Life Sciences, and Artūras Pažera, Senior Clinical Project Manager at Biomapas, to discuss key...
Running Pan‑European Multi‑Regional Trials with Flexible FSP Models
Navigating Multi‑Country Complexity Without Losing Control European trials now routinely span dozens of countries. The push toward harmonization under the EU Clinical Trials Regulation (CTR) has smoothed some paths, but local differences in ethics reviews, language,...
Enhancing Patient Recruitment in Niche Markets Through Clinical Trial Outsourcing
Patient recruitment is often the main challenge in clinical research. Small biotech companies with limited resources and tight deadlines may miss enrollment goals, putting studies at risk. Clinical trial outsourcing controls costs and is a strategic tool that helps...
